Global and United States Antibody Development Services Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Antibody Development Services Market
This report focuses on global and United States Antibody Development Services market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Antibody Development Services market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Monoclonal Antibody Development accounting for % of the Antibody Development Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Medical Industry was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Antibody Development Services market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Antibody Development Services Scope and Market Size

Antibody Development Services market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Antibody Development Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Antibody Development Services market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Antibody Development Services market is segmented into

Monoclonal Antibody Development

Polyclonal Antibody Development

Segment by Application, the Antibody Development Services market is segmented into

Medical Industry

Biological Industry

Others

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Antibody Development Services Market Share Analysis

Antibody Development Services market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody Development Services business, the date to enter into the Antibody Development Services market, Revenue in Antibody Development Services Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Thermo Fisher Scientific

R&D Systems

Leinco Technologies

Rockland Immunochemicals, Inc. (Rockland)

Bio-Rad

BioGenes

ProteoGenix

Labcorp

Inotiv, Inc.

ProMab Biotechnologies

Kemp Proteins

Synaptic Systems

ARVYS Proteins, Inc.

BBI Solutions

Innovagen AB

BIOTEM

Medimab

OriGene

Abeomics Inc.

RayBiotech

Genscript Biotech Corporation

Sino Biological

Abzena Ltd

Creative Biolabs

Abcam

Antibodies Incorporated